Skip to the content
Neurodexlogo darklogo light
  • Home
  • About Us
    • Our Team
    • Neurodex Laboratories
  • Our Tech
    • ExoSort Platform
    • Our Projects
    • Publications
    • Pipeline
  • Services
    • Neurodiagnostic Platform
    • Research Services
    • ⁠Pre-Clinical Services
    • Clinical Trial Services
  • NeuroDex News
  • Contact Us
Neurodexlogo darklogo light
HomePosted by Victoria Akhiezer(Page 2)
Dr. Erez Eitan to Participate in the Alzheimer’s Association International Conference (AAIC) 2025
NeuroDex News

Dr. Erez Eitan to Participate in the Alzheimer’s Association International Conference (AAIC) 2025

Victoria Akhiezer
July 14, 2025
Alzheimer's Disease
Explanation Material

Alzheimer’s Disease

Victoria Akhiezer
July 1, 2025
Parkinson’s Disease: Symptoms, Causes, and Treatment
Explanation Material

Understanding Parkinson’s Disease: Symptoms, Causes, and Treatment

Victoria Akhiezer
July 1, 2025
Neurodegenerative Diseases Overview
Explanation Material

Neurodegenerative Diseases Overview

Victoria Akhiezer
July 1, 2025
Alpha synuclein kit
Explanation Material

Biomarkers

Victoria Akhiezer
July 1, 2025
Exosomes
Explanation Material

Exosomes

Victoria Akhiezer
July 1, 2025
Lewy Body Dementia (LBD)
Explanation Material

Lewy Body Dementia (LBD)

Victoria Akhiezer
July 1, 2025
NeuroDex Pioneers New Multi-Pronged Biomarker for Neurodegenerative Diseases
NeuroDex News

NeuroDex Pioneers New Multi-Pronged Biomarker for Neurodegenerative Diseases

Victoria Akhiezer
November 12, 2024
Target ALS
NeuroDex News

NeuroDex Awarded Target ALS Biomarker Consortia Grant to Drive Advancements in ALS Research

Victoria Akhiezer
November 7, 2024
Dr. Erez Eitan to Participate in the Alzheimer’s Association International Conference (AAIC) 2024
NeuroDex News

Dr. Erez Eitan to Participate in the Alzheimer’s Association International Conference (AAIC) 2024

Victoria Akhiezer
July 25, 2024

Posts pagination

1 2 3

Contact Us

Company

NeuroDex Inc

  • 22 Strathmore Road
  • Natick, MA US 01760
  • info@neurodex.co
Information
  • Terms & Conditions
  • Privacy Policy
  • Neurodex FAQ
Resources
  • Explanation Material
  • NeuroDex News
  • Blog
Back to top Drag
  • Home
  • About Us
    • Our Team
    • Neurodex Laboratories
  • Our Tech
    • ExoSort Platform
    • Our Projects
    • Publications
    • Pipeline
  • Services
    • Neurodiagnostic Platform
    • Research Services
    • ⁠Pre-Clinical Services
    • Clinical Trial Services
  • NeuroDex News
  • Contact Us
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}